Project Grant R01NS140965

Award Date 12/15/24
Completion Date 11/30/28
Dollars Obligated $909K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92037, USA
Similar Awards
This $869,478 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to elucidate the fundamental mechanisms of neurodegeneration in hereditary prion diseases. The 5-year project, awarded to Trustees of Boston University's Medical Campus starting on June 1, 2025, will: Analyze the properties of the E200K prion protein mutation in induced...
The University of California, San Diego (UCSD) has been awarded a $434,500 Project Grant by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This 2-year grant will support research to determine the signaling pathways activated by prion protein in human induced pluripotent stem cell (iPSC)-derived neurons. The research aims to establish the sequence of intracellular...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $322,962 to Northwestern University to conduct research on understanding the role of prion-mediated transcriptional modifications and cellular phenotypes. The key objectives of this 4-year project are to: 1) characterize variants of the [SWI+] prion and their distinct transcriptomic and phenotypic effects; 2) examine...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $628,726 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Priogen Corp. to develop a portable, microfluidic device called Micro-QUIC for the rapid detection of misfolded prion proteins that cause transmissible spongiform encephalopathies (TSEs). The 2.5-month project, starting on May 15, 2025, aims to: (1) optimize the Micro-QUIC assay to distinguish between native and misfolded...
The National Science Foundation Division of Environmental Biology awarded a $358,777 Project Grant to the College of William and Mary under the Biological Sciences federal grant program (CFDA 47.074) to fund collaborative research from July 2022 to June 2026. The research aims to advance understanding of how natural selection impacts prions, which are protein-based infectious agents that can cause diseases like mad cow disease, at multiple levels from molecules to biological communities....
The National Science Foundation awarded a $1,027,074 Project Grant to Stanford University under the Biological Sciences federal grant program (CFDA 47.074) for work spanning July 15, 2022 to June 30, 2026. The award will support research examining how natural selection impacts prions, which are proteins that can replicate across generations and in some cases cause disease, at multiple levels from molecules to biological communities. Specifically, the grantee will conduct an experimental...
This federal Project Grant award of $2,307,075, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders, supports an ambitious research program at Stanford University focused on defining novel mechanisms of human neurodegenerative diseases and translating those findings into new therapeutic strategies. The key objectives of this grant include: 1) Conducting genome-wide...
This $168,321 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to investigate the mechanisms regulating the folding, trafficking, and degradation of the NPC1 protein in human neurons. The award recipient, the Regents of the University of Michigan, will use induced human stem cell-derived neurons to measure NPC1 function and...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $2,503,949 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Rockefeller University. The grant, awarded on May 1, 2025, supports a research project titled "Applying RNA Logic in Space and Time to Neurologic Disease". The project aims to develop new techniques and concepts to discover therapeutic targets for neurological diseases by studying...
The federal Project Grant award of $621,500 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The goal of the project is to develop new methods for combined molecular and ultrastructural imaging of neural cells and tissues using advanced nanoprobes and cathodoluminescent dyes. Specifically, the award will fund the development of (1) detergent-free...

This Project Grant award, with a total funding amount of $909,090, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award supports research aimed at developing a therapeutic strategy to treat prion diseases, a rare class of neurodegenerative disorders. Specifically, the grant will fund investigations into a small molecule compound, A5, that activates macroautophagy to clear neurotoxic prion protein aggregates in neuronal axons. The research, conducted by the Scripps Research Institute in La Jolla, CA, will assess the efficacy of A5 in neuronal and mouse models of familial and infectious prion disease, as well as elucidate the mechanism of action of A5. The award period spans from Dec 15, 2024 to Nov 30, 2028.

Generated 8/5/25, 5:04 AM